Clinical Trial

Impact of the Use of Allogeneic Hematopoietic Stem Cell Transplantation in Reunion Island Patients: Quality of Life, Determinants of Choices and Financial Repercussions

Study acronym: AlloRé
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This project aims to document and analyse - with a three-fold anthropological, psychosocial and economical approach - the consequences of the geographical distance from mainland France on the alloSCT on both patients, their caregivers and the healthcare system. It is organised in 3 working packages (WP).
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2022-04-07.
Trial Details
NCT Number NCT05327673
Lead Sponsor Centre Hospitalier Universitaire de la Réunion
Collaborators: Institut Paoli-Calmettes
Conditions Allogeneic Hematopoietic Stem Cell Transplantation
Enrollment 100 participants
Start Date 2022-07
Primary Completion 2027-01 (estimated)
Study Completion 2027-03 (estimated)
Updated on ClinicalTrials.gov 2022-04-21